Analysis Of The Relationship Between HBA1C and Serum Galectin-3 Levels in Subjects With Type 2 Of Diabetes Mellitus
Abstract
Type 2 diabetes mellitus is a disease characterized by increased blood glucose levels known as hyperglycemia. This disease can be diagnosed by examining HbA1c (glycated hemoglobin). Hemoglobin A1c is a minor component of hemoglobin related to glucose. Meanwhile, galectin-3 is a protein encoded in humans by the LGALS3 gene. This study aimed to clarify the relationship between HbA1c and serum galectin-3 levels in patients with type 2 diabetes. This study was conducted using an observational analysis technique with a cross-sectional study design. This research was conducted at the Clinical Pathology Laboratory, Hasanuddin University State University Hospital, and Laboratorium Universitas Hasanuddin Medical Research Center State College Hospital Universitas Hasanuddin Makassar. This research was conducted from January to March 2023. The population in this study were all patients with type 2 DM who visited the Hasanuddin University Hospital (RSPTN-UH) for treatment a total of 112 patients. Research sampling technique with non-probability purposive sampling. The sample of this study was 60 patients. Data analysis with the Independent T-test or Mann-Whitney test. The results of the study were that serum Galectin-3 levels in uncontrolled type 2 diabetes mellitus had a higher average value of 20.18 ± 6.15 ng/mL compared to controlled type 2 diabetes mellitus, namely 14.80 ± 6.41 ng/ mL although there was a statistically significant difference (p=0.012) but no significant correlation was found between HbA1c and serum Galectin-3 levels in type 2 diabetes mellitus subjects (r=0.176 p=0.179) with the distribution of data in the Scatterplot not forming a linear relationship pattern. It is recommended that type 2 Diabetes Mellitus patients carry out an HbA1c examination as an effective test to control glucose levels, reduce the risk of complications, and maintain a healthy lifestyle to avoid type 2 DM.
Full Text:
PDFReferences
Decroli, E. (2019). Diabetes melitus tipe 2. Padang: Pusat Penerbitan Bagian Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Andalas, 1–52.
Donelly, R., & Bilous, R. (2014). Buku Pegangan Diabetes Edisi Ke-4. Yogyakarta: Bumi Medika.
Driyah, S., Oemiati, R., & Riyadina, W. (2020). Indikator HbA1c pada Responden DM pada Studi Kohor Faktor Risiko Penyakit Tidak Menular di Kota Bogor, Indonesia 2017: Korelasi Kadar Glukosa Darah dan Kolesterol Total. Jurnal Biotek Medisiana Indonesia, 9(2), 81–89. https://doi.org/https://doi.org/10.22435/jbmi.v9i2.4411
Ermawati, N., Prakoso, S. A., Shofi, M., & Andayani, A. (2022). Hubungan Kadar HbA1c dengan Nilai Laju Endap Darah Pada Penderita Diabetes Mellitus Di RSU Daha Husada Kota Kediri. Jurnal Sintesis Penelitian Sains Terapan Dan Analisisnya, 3(2), 1–8. https://doi.org/https://doi.org/10.56399/jst.v3i2.30
Johannes, L., Jacob, R., & Leffler, H. (2018). Galectins at a glance. Journal of Cell Science, 131(9), 1–9. https://doi.org/10.1242/jcs.208884
Kemenkes RI. (2018). Laporan Nasional Riskesdas 2018. Jakarta : Kementerian Kesehatan RI. Retrieved from https://www.litbang.kemkes.go.id/laporan-riset-kesehatan-dasar-riskesdas/
Kemenkes RI. (2020). NFODATIN Pusat Data dan Informasi Kementrian Kesehatan RI Tetap Produktif, Cegah dan Atasi Diabetes Melitus (Jakarta : Kementerian Kesehatan RI, ed.). Jakarta : Kementerian Kesehatan RI. Retrieved from https://www.kemkes.go.id/downloads/resources/download/pusdatin/infodatin/Infodatin 2020 Diabetes Melitus.pdf
Li, Y.-S., Li, X.-T., Yu, L.-G., Wang, L., Shi, Z.-Y., & Guo, X.-L. (2020). Roles of galectin-3 in metabolic disorders and tumor cell metabolism. International Journal of Biological Macromolecules, 142(1), 463–473. https://doi.org/https://doi.org/10.1016/j.ijbiomac.2019.09.118
Li, Y., Li, T., Zhou, Z., & Xiao, Y. (2022). Emerging roles of Galectin-3 in diabetes and diabetes complications: A snapshot. Reviews in Endocrine and Metabolic Disorders, 23(3), 569–577. https://doi.org/10.1007/s11154-021-09704-7
Lin, D., Hong, X., Sun, K., Zhang, X., Lian, H., Wang, J., … You, L. (2021). Galectin-3 / adiponectin as a new biological indicator for assessing the risk of type 2 diabetes : a cross-sectional study in a community population. Aging (Albany NY), 13(11), 15433–15443. https://doi.org/https://doi.org/10.18632/aging.203101
Lok, D. J. A., Van Der Meer, P., de la Porte, P. W., Lipsic, E., Van Wijngaarden, J., Hillege, H. L., & van Veldhuisen, D. J. (2010). Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clinical Research in Cardiology, 99(5), 323–328.
Ma, S., Li, S., Lv, R., Hou, X., Nie, S., & Yin, Q. (2020). Prevalence of mild cognitive impairment in type 2 diabetes mellitus is associated with serum galectin-3 level. Journal of Diabetes Investigation, 11(5), 1295–1302. https://doi.org/10.1111/jdi.13256
Owora, A. H. (2018). Diagnostic validity and clinical utility of HbA1c tests for type 2 diabetes mellitus. Current Diabetes Reviews, 14(2), 196.
Ozturk, D., Celik, O., Satilmis, S., Aslan, S., Erturk, M., Cakmak, H. A., … Gul, M. (2015). Association between serum galectin-3 levels and coronary atherosclerosis and plaque burden/structure in patients with type 2 diabetes mellitus. Coronary Artery Disease, 26(5), 396–401.
Powers, A. (2005). No Title. Diabetes Mellitus in Harrison’s Principles of Internal Medicine, 2 MCGraw-H(2152-63.).
Punthakee, Z., Goldenberg, R., & Katz, P. (2018). Definition, classification and diagnosis of Diabetes, prediabetes and metabolic syndrome. Canadian Journal of Diabetes, 42, S10–S15.
Que, A., Yasa, I. W. P. S., & Lestari, A. A. W. (2015). Gambaran Hasil Pemeriksaan Kadar Hba1c Pada Penderita Diabetes Mellitus di Laboratorium Rumah Sakit Umum Surya Husadha Tahun 2013. E-Jurnal Medika Udayana, pp. 1395–2303. dec.
Rahmawati, C., Aini, & Ramadani. (2019). Pengaruh Dosis Antikoagulan Edta 10% Dan Natrium Sitrat 3,8% Pada Pemeriksaan Laju Endap Darah. Jurnal Penelitian Dan Kajian Ilmiah Kesehatan Volume, 5(1), 79–85. https://doi.org/https://doi.org/10.33651/jpkik.v5i1.25
Sa’diyah, I. F., Abidin, F. P., Purba, L. A., & Yuniasari, H. (2018). Efek Anti-Angiogenesis Ekstrak Kayu Secang Sebagai Terapi Adjuvant pada Diabetes Retinopati. Saintika Medika, 14(2), 114–118. https://doi.org/10.22219/sm.vol14.smumm2.7160
Vora, A., De Lemos, J. A., Ayers, C., Grodin, J. L., & Lingvay, I. (2019). Association of galectin-3 with Diabetes mellitus in the dallas heart study. The Journal of Clinical Endocrinology & Metabolism, 104(10), 4449–4458.
Wang, J., Luo, X., Jin, X., Lv, M., Li, X., Dou, J., … Mu, Y. (2020). Effects of Preoperative HbA1c Levels on the Postoperative Outcomes of Coronary Artery Disease Surgical Treatment in Patients with Diabetes Mellitus and Nondiabetic Patients: A Systematic Review and Meta-Analysis. Journal of Diabetes Research, 2020, 1–14. https://doi.org/10.1155/2020/3547491
Weigert, J., Neumeier, M., Wanninger, J., Bauer, S., Farkas, S., Scherer, M. N., … Scha, A. (2010). Serum Galectin-3 Is Elevated in Obesity and Negatively Correlates with Glycosylated Hemoglobin in Type 2 Diabetes. J Clin Endocrinol Metab, 95(March), 1404–1411. https://doi.org/10.1210/jc.2009-1619
WHO. (2016). Global report on Diabetes. World Health Organization. Retrieved from https://apps.who.int/iris/bitstream/handle/10665/204871/9789241565257_eng.pdf;jsessionid=F543DBAEA2B8AF04D952A160303A76B5?sequence=1
Widowati, W. (2007). Peran antioksidan sebagai agen hipokolesterolemia, pencegah oksidasi lipid dan ateroskeloris. Widowati, W. 2007. Peran antioksidan Majalah Kedokteran Damianus 6: 227-232.
Zheng, Y., Ley, S. H., & Hu, F. B. (2018). Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Reviews Endocrinology, 14(2), 88–98. https://doi.org/10.1038/nrendo.2017.151
Zulfian, Anggunan, Sukma, V., & Syuhada. (2022). Hubungan Kadar HbA1c dengan Kadar Kreatinin Serum Pada Penderita Diabetes Melitus Tipe 2 di Rumah Sakit Pertamina Bintang Amin Husada, Bandar Lampung Tahun 2022. Medula (Medical Profession Journal of Lampung), 12(2), 224–230. https://doi.org/https://doi.org/10.53089/medula.v12i2.362
DOI: http://dx.doi.org/10.30829/contagion.v5i2.15076
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Zaifah Firayanti, Yuyun Widaningsih, Liong Boy Kurniawan, Himawan Sanusi, Andi Alfian Zainuddin, Tenri Esa
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
